Chimerix and BARDA Announce Continued Partnership in the Development of Brincidofovir for Smallpox $17.0 Million Awarded in Latest Contract Extension DURHAM, N.C., Sept. 2, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company...
MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome Data from Multi-Center, Placebo-Controlled Study Anticipated in Q1 2015 SAN DIEGO, Sept. 2, 2014 /PRNewswire/ — MEI Pharma, Inc. (Nasdaq:...
Chimerix’s Brincidofovir Has in Vitro Activity Against Ebola Chimerix Attending World Health Organization Conference in Geneva DURHAM, N.C., Sept. 3, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral...
Kit Check Tracks Two Million Hospital Medications With RFID Great Falls, MT – September 3, 2014 – Kit Check™ (http://kitcheck.com), the leader in hospital pharmacy kit processing and medication tracking software, today announced that hospital users have tracked two...
Spiracur’s SNaP Wound Care System Awarded Coverage by Health Care Services Corporation SUNNYVALE, Calif., Sept. 4, 2014 – Spiracur, the developer of the only mechanically powered advanced wound care solution that delivers the proven efficacy of Negative Pressure Wound...
Recent Comments